Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
54 /100
HIGH RISK
Score updated Aug 28, 2026

SLDB — Solid Biosciences Inc. Dilution Risk Tracker

Track SLDB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SLDB — Get alerts when the score changes →

As of August 28, 2026, Solid Biosciences Inc. (SLDB) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. Solid Biosciences Inc. has a market capitalization of $722.62M, 107.23M shares outstanding, 142 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise model 20%
• Active shelf registration ($100M, 14% of market cap)
🔔 Track SLDB — Get forecast alerts →

Market Data

Market Cap$722.62M
Shares Outstanding107.23M
Float53.74M
Cash$159.39M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 40.2% shares (2026Q1 vs prior)
142 institutional holders · 118.89M shares
#1 PERCEPTIVE ADVISORS LLC 23.81M shares
#2 Bain Capital Life Sciences Investors, LLC 9.81M shares
#3 RA CAPITAL MANAGEMENT, L.P. 9.34M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.04M
Days to Cover16.2
% of Float31.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
S-3 SHELF 2026-03-19
S-3 SHELF 2026-03-19
4 INSIDER TRANSACTION 2026-03-11
8-K 8K EVENT 2026-03-06
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SLDB Dilution Snapshot

Solid Biosciences Inc. (SLDB) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SLDB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SLDB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SLDB
SLDB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.